Nektar shareholders elect three directors, approve 8M share increase, ratify auditor

NEKTAR THERAPEUTICS

Elected directors Jeff Ajer, Robert B. Chess, Roy A. Whitfield with broker non-votes of 46.7M each.
Approved amendment to 2017 Performance Incentive Plan adding 8M shares; 86.5M for, 7.5M against.
Ratified Ernst & Young as independent auditor for FY2024: 139M for, 1.6M against, 6M abstain.
Non-binding say-on-pay approved: 87M for, 6.7M against, 6.2M abstain.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.